Domů › Metastatický karcinom › Distrikt Kolumbie › Washington
Klinické studie Metastatický karcinom v Washington, DC
43 studií pro Metastatický karcinom hledá účastníky v lokalitách v Washington a okolí (do cca 30 mil). Otevřete studii a zjistěte, kdo se může zapojit a jak kontaktovat tým studie.
Oficiální text studie (anglicky)
Hledáte účastníky pro studii? Zvýrazněte ji nahoře na této stránce – $99 na 30 dní →
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
Probíhá náborFáze 2
- Walter Reed National Military Medical Center, Bethesda · Vzdálenost 7 mi
- National Institutes of Health Clinical Center, Bethesda · Vzdálenost 7 mi
The Role of 68-Gallium-DOTATATE-PET/CT in the Imaging of Metastatic Thyroid Cancer
Probíhá náborFáze 2
- National Institutes of Health Clinical Center, Bethesda · Vzdálenost 7 mi
A Study of ASP3082 in Adults With Advanced Solid Tumors
Probíhá náborFáze 1
- Georgetown University Hospital, Washington D.C.
Zanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine Tumors
Probíhá náborFáze 2/3
- Georgetown University, Washington D.C.
A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors
Probíhá náborFáze 1
- Johns Hopkins Sibley Memorial Hospital, Washington D.C.
ASPEN-09-03: A Study of Evorpacept in Combination With Trastuzumab and Chemotherapy in Metastatic HER2-Positive Breast Cancer
Probíhá náborFáze 2
- The George Washington Medical facility Associates, Washington D.C.
A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue
Probíhá náborFáze 2/3
- Georgetown University Medical Center - Department of Pharmacy, Oncology Pharmacy, Washington D.C.
- Georgetown University Medical Center, Washington D.C.
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
Probíhá náborFáze 3
- Maryland Oncology Hematology, P.A., Silver Spring · Vzdálenost 7 mi
- Maryland Oncology Hematology, P.A., Bethesda · Vzdálenost 7 mi
- Maryland Oncology Hematology, P.A., Largo · Vzdálenost 11 mi
A Study of Zidesamtinib (NVL-520) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ROS1 Rearrangement (ARROS-1)
Probíhá náborFáze 1/2
- Georgetown University Medical Center, Washington D.C.
A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
Probíhá náborFáze 3
- MedStar Washington Hospital Center, Washington D.C.
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
Probíhá náborFáze 3
- MedStar Washington Hospital Center, Washington D.C.
- American Oncology Partners, PA, Bethesda · Vzdálenost 7 mi
A Clinical Study of Ifinatamab Deruxtecan Based Treatment Combinations or as Monotherapy to Treat Metastatic Castrate Resistant Prostate Cancer (mCRPC) (MK-2400-01A/IDeate-Prostate02)
Probíhá náborFáze 1/2
- MedStar Georgetown Cancer Institute at MedStar Washington Hospital Center ( Site 0026), Washington D.C.
Testing How the Body Responds to the Drug CX-5461 (Pidnarulex) in Patients With Metastatic Solid Cancers
Probíhá náborFáze 1
- National Cancer Institute Developmental Therapeutics Clinic, Bethesda · Vzdálenost 7 mi
CR-001 in Adult Participants With Locally Advanced or Metastatic Solid Tumors
Probíhá náborFáze 1/2
- Clinical Study Site, Washington D.C.
The Use of 124-I-PET/CT Whole Body and Lesional Dosimetry in Differentiated Thyroid Cancer
Probíhá náborFáze 2
- National Institutes of Health Clinical Center, Bethesda · Vzdálenost 7 mi
Durvalumab in Combination With Chemotherapy in Treating Patients With Advanced Solid Tumors, DURVA+ Trial
Probíhá náborFáze 2
- National Cancer Institute Developmental Therapeutics Clinic, Bethesda · Vzdálenost 7 mi
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
Probíhá náborFáze 3
- Sibley Memorial Hospital, Washington D.C.
AVENTINE-1: Study of AVZO-1418 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (AVZO-1418-1001)
Probíhá náborFáze 1/2
- Avenzo Therapeutics Recruiting Site, Washington D.C.
Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.
Probíhá náborFáze 3
- The Center for Cancer and Blood Disorders a division of American Oncology Partners, P.A., Bethesda · Vzdálenost 7 mi
T Cell Receptor Immunotherapy for Patients With Metastatic Non-Small Cell Lung Cancer
Probíhá náborFáze 2
- National Institutes of Health Clinical Center, Bethesda · Vzdálenost 7 mi
Testing the Combination of Two Anti-cancer Drugs, Peposertib (M3814) and Tuvusertib (M1774) for Advanced Solid Tumors
Probíhá náborFáze 1
- National Cancer Institute Developmental Therapeutics Clinic, Bethesda · Vzdálenost 7 mi
A Study of Novel Study Interventions and Combinations in Participants With Colorectal Cancer
Probíhá náborFáze 2
- Research Site, Washington D.C.
FOG-001 in Locally Advanced or Metastatic Solid Tumors
Probíhá náborFáze 1/2
- Johns Hopkins University, Sibley Memorial Hospital, Washington D.C.
Testing How the Body Responds to the Drug CBX-12 in Patients With Advanced Solid Cancers
Probíhá náborFáze 1
- National Cancer Institute Developmental Therapeutics Clinic, Bethesda · Vzdálenost 7 mi
Studying the Safety and Determining the Optimal Dose of Novobiocin in Patients With Tumors That Have Alterations in DNA Repair Genes
Probíhá náborFáze 1
- National Cancer Institute Developmental Therapeutics Clinic, Bethesda · Vzdálenost 7 mi
Testing the Combination of the Anti-Cancer Drugs Temozolomide and M1774 to Evaluate Their Safety and Effectiveness
Probíhá náborFáze 1/2
- National Cancer Institute Developmental Therapeutics Clinic, Bethesda · Vzdálenost 7 mi
Puxitatug Samrotecan (AZD8205) Monotherapy vs Chemotherapy in B7-H4-selected Endometrial Cancer (Bluestar-Endometrial01)
Probíhá náborFáze 3
- Research Site, Washington D.C.
- Research Site, Silver Spring · Vzdálenost 7 mi
Study of mRNA-4359 Administered Alone and in Combination With Immune Checkpoint Blockade in Participants With Advanced Solid Tumors
Probíhá náborFáze 1/2
- George Washington University, Washington D.C.
(Peak) A Phase 3 Randomized Trial of CGT9486+Sunitinib vs. Sunitinib in Subjects With Gastrointestinal Stromal Tumors
Probíhá náborFáze 3
- MedStar Washington Hospital Center, Washington D.C.
E7 TCR-T Cell Immunotherapy for Human Papillomavirus (HPV) Associated Cancers
Probíhá náborFáze 2
- National Institutes of Health Clinical Center, Bethesda · Vzdálenost 7 mi
A Study of Neladalkib (NVL-655) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ALK Rearrangement or Activating ALK Mutation (ALKOVE-1)
Probíhá náborFáze 1/2
- Georgetown University Medical Center, Washington D.C.
Phase 3 Study of Gedatolisib as First-Line Treatment for Patients With HR-Positive, HER2-Negative Advanced Breast Cancer (VIKTORIA-2)
Probíhá náborFáze 3
- American Oncology Partners, P.A., Bethesda · Vzdálenost 7 mi
Studying TAK-243 in Patients With Advanced Cancer
Probíhá náborFáze 1
- National Cancer Institute Developmental Therapeutics Clinic, Bethesda · Vzdálenost 7 mi
Safety and Efficacy of EIK1001 in Combo With Pembro Versus Placebo and Pembro as First-Line Therapy in Patients With Advanced Melanoma.
Probíhá náborFáze 2/3
- The Center for Cancer and Blood Disorders, Bethesda · Vzdálenost 7 mi
Cancer Experience Registry (CER) for Cancer Patients and Caregivers
Probíhá náborObservační studieVítáni zdraví dobrovolníci
- Cancer Support Community Research & Training Institute, Washington D.C.
A Study of Ficlatuzumab in Combination With Cetuximab in Participants With Recurrent or Metastatic (R/M) HPV Negative Head and Neck Squamous Cell Carcinoma
Probíhá náborFáze 3
- The George Washington University, Washington D.C.
Veterans Affairs Seamless Phase II/III Randomized Trial of STAndard Systemic theRapy With or Without PET-directed Local Therapy for Oligometastatic pRosTate Cancer
Probíhá náborFáze 2/3
- Washington DC VA Medical Center, Washington, DC, Washington D.C.
A Randomized, Phase 2/3 Study to Investigate the Efficacy and Safety of RP2 in Combination With Nivolumab in Immune Checkpoint Inhibitor-Naïve Adult Patients With Metastatic Uveal Melanoma
Probíhá náborFáze 2/3
- Georgetown University Medical Center, Washington D.C.
Phase I Study of Tolododekin Alfa (ANK-101) in Advanced Solid Tumors
Probíhá náborFáze 1
- National Cancer Institute, Bethesda · Vzdálenost 7 mi
A Study of NVL-330 in Patients With Advanced or Metastatic HER2-altered NSCLC (HEROEX-1)
Probíhá náborFáze 1
- Georgetown University Medical Center, Washington D.C.
- Sibley Memorial Hospital, Washington D.C.
Evaluation of RBS2418 in Subjects With Advanced, Metastatic Solid Tumors
Probíhá náborFáze 1
- American Oncology Partners of Maryland, Bethesda · Vzdálenost 7 mi
VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma
Probíhá náborFáze 1/2
- The George Washington University Cancer Center (site 212), Washington D.C.
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Probíhá náborObservační studie
- Massive Bio SYNERGY-AI site, Silver Spring · Vzdálenost 7 mi
- Massive Bio SYNERGY-AI site, Bethesda · Vzdálenost 7 mi
Studie Metastatický karcinom v jiných městech
- Houston, TX104 studií
- New York City, NY93 studií
- Nashville, TN70 studií
- Boston, MA63 studií
- Los Angeles, CA57 studií
- St. Louis, MO54 studií
- Arlington, VA53 studií
- Philadelphia, PA46 studií
- Chicago, IL45 studií
- San Antonio, TX44 studií
- Dallas, TX42 studií
- Seattle, WA39 studií
Další studie v Washington
- Rakovina (všechny typy)58 studií
- Nemalobuněčný plicní karcinom55 studií
- Rakovina prsu46 studií
- Rakovina plic41 studií
- Rakovina prostaty38 studií
- Obesity33 studií
- Kolorektální karcinom29 studií
- Kardiovaskulární onemocnění28 studií
- Rakovina močového měchýře26 studií
- Akutní myeloidní leukemie24 studií
- Rakovina vaječníků23 studií
- Lymfom23 studií
Zdroj: ClinicalTrials.gov, data načtena 6. 10. 2026. Každá studie má vlastní kritéria způsobilosti; o účasti rozhoduje tým studie.